Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 14,809 | 8,520 | 25,706 | 13,008 | 113,721 |
| Gross Profit | 14,809 | 8,520 | 25,706 | 13,008 | 113,721 |
| Operating Expenses | 80,067 | 76,439 | 74,391 | 69,599 | 70,569 |
| Operating Income | -65,258 | -67,919 | -48,685 | -56,591 | 43,152 |
| Other Income | -4,830 | 19,132 | 675 | -1,622 | 3,720 |
| Pre-tax Income | -70,088 | -48,787 | -48,010 | -58,213 | 46,872 |
| Income Tax | 2,355 | N/A | 8 | N/A | 15,807 |
| Net Income Continuous | -72,443 | -48,787 | -48,018 | -58,213 | 31,065 |
| Net Income | $-72,443 | $-48,787 | $-48,018 | $-58,213 | $31,065 |
| EPS Basic Total Ops | -8.10 | -5.90 | -5.90 | -9.50 | 5.20 |
| EPS Basic Continuous Ops | -8.07 | -5.95 | -5.91 | -9.47 | 5.29 |
| EPS Diluted Total Ops | -8.10 | -5.90 | -5.90 | -9.50 | 5.20 |
| EPS Diluted Continuous Ops | -8.07 | -5.95 | -5.91 | -9.47 | 5.29 |
| EPS Diluted Before Non-Recurring Items | -8.90 | -5.90 | -5.90 | -9.50 | N/A |
| EBITDA(a) | $-64,929 | $-68,817 | $-49,722 | $-57,486 | $41,830 |